TELMIN B SYRINGE FORMULA DIN 00755796
Health Canada record
| Active ingredient(s) | MEBENDAZOLE 100 MG; TRICHLORFON 459 MG |
|---|---|
| Dosage form | Paste |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1988 |
| Current status date | 29-Jan-2010 |
| Source | Health Canada DPD |
Establishment licence of the holder
Janssen Inc — licence 100239, currently licensed, last inspection rating C (2026-03-09).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MEBENDAZOLE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00556734 | VERMOX | JANSSEN INC | Tablet | MEBENDAZOLE 100 MG | Marketed |
| 02243944 | BOT-PLUS SYRINGE FORMULA EQUINE WORMER | CAN-VET ANIMAL HEALTH SUPPLIES LTD. | Paste | MEBENDAZOLE 100 MG; TRICHLORFON 459 MG | Dormant |
| 00540773 | EQUIVERM 200MG/GM | DAVIS AND LAWRENCE CO. | Powder | MEBENDAZOLE 200 MG | Cancelled Post Market |
| 00540765 | EQUIVERM B PST | DAVIS AND LAWRENCE CO. | Powder | MEBENDAZOLE 100 MG; TRICHLORFON 459 MG | Cancelled Post Market |
| 00755788 | TELMIN SYRINGE FORMULA | JANSSEN PHARMACEUTICA N.V. | Paste | MEBENDAZOLE 200 MG | Cancelled Post Market |
| 00889148 | WORM-AWAY IV | SERGEANTS OF CANADA | Tablet | MEBENDAZOLE 100 MG | Cancelled Post Market |
International API supply for MEBENDAZOLE
6 active FDA Drug Master Files.
Request a quote for TELMIN B SYRINGE FORMULA